Scientists at UCL say drug developers should focus on two risk-raising variants of the Apoe gene New therapies for Alzheimer’s disease should target a particular gene linked to the condition, according to researchers who said most cases would never arise if its harmful effects were neutralised. The call to action follows the arrival of the […] →Read more
Plasma proteomic signatures associate with near-future Alzheimer’s disease dementia conversion in mild cognitive impairment patients – Nature
A leading charity said it was “deeply concerning” that emergency legislation was needed for the Mental Health Review Tribunal for Wales, which assesses the cases of people sectioned or otherwise … →Read more
The House Article | To ease NHS winter pressures, we must get dementia diagnosis right – Politics Home